SWOT Analysis for scPharmaceuticals Inc

Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Increasing Revenue every Quarter for the past 4 Quarters
Stock with Low PE (PE < = 10)

Companies with growing costs YoY for long term projects
Stocks with Quarter Change % less than Industry
New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Top Losers
Companies with Increasing Debt
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter